Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC By Ogkologos - July 14, 2025 496 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IMforte study Source RELATED ARTICLESMORE FROM AUTHOR A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis MOST POPULAR The link between Down syndrome and childhood leukaemia September 1, 2022 Lung cancer screening can’t leave anyone in the UK behind July 27, 2023 Lung Adenocarcinoma with Mucinous Histology December 16, 2024 Combination of Nivolumab and Ipilimumab Yields Better Outcomes Compared to Ipilimumab... September 12, 2023 Load more HOT NEWS Sentinel Lymph Node Biopsy Navigated Neck Dissection Is Not Inferior to... DIY Mosquito Traps & Deterrents (That Really Work) Breast Cancer Centers Rarely Follow National Screening Recommendations, Study Says Investing in volunteers since 2002: The tale of time
